Brazilian court clears GSK/Pfizer divestiture
A federal judge in Brazil has reportedly approved Pfizer's sale of assets to Aspen Pharmacare, ending a suspension caused by lack of quorum at the country’s competition watchdog.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.